Correlation Between Annovis Bio and Reata Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Annovis Bio and Reata Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Annovis Bio and Reata Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Annovis Bio and Reata Pharmaceuticals, you can compare the effects of market volatilities on Annovis Bio and Reata Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Annovis Bio with a short position of Reata Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Annovis Bio and Reata Pharmaceuticals.
Diversification Opportunities for Annovis Bio and Reata Pharmaceuticals
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Annovis and Reata is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Annovis Bio and Reata Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Reata Pharmaceuticals and Annovis Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Annovis Bio are associated (or correlated) with Reata Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Reata Pharmaceuticals has no effect on the direction of Annovis Bio i.e., Annovis Bio and Reata Pharmaceuticals go up and down completely randomly.
Pair Corralation between Annovis Bio and Reata Pharmaceuticals
Given the investment horizon of 90 days Annovis Bio is expected to generate 6.52 times less return on investment than Reata Pharmaceuticals. But when comparing it to its historical volatility, Annovis Bio is 2.03 times less risky than Reata Pharmaceuticals. It trades about 0.03 of its potential returns per unit of risk. Reata Pharmaceuticals is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest 3,962 in Reata Pharmaceuticals on August 26, 2024 and sell it today you would earn a total of 7,005 from holding Reata Pharmaceuticals or generate 176.8% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 31.99% |
| Values | Daily Returns |
Annovis Bio vs. Reata Pharmaceuticals
Performance |
| Timeline |
| Annovis Bio |
| Reata Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Annovis Bio and Reata Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Annovis Bio and Reata Pharmaceuticals
The main advantage of trading using opposite Annovis Bio and Reata Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Annovis Bio position performs unexpectedly, Reata Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Reata Pharmaceuticals will offset losses from the drop in Reata Pharmaceuticals' long position.| Annovis Bio vs. Cassava Sciences | Annovis Bio vs. Axsome Therapeutics | Annovis Bio vs. Reviva Pharmaceuticals Holdings | Annovis Bio vs. Seres Therapeutics |
| Reata Pharmaceuticals vs. Sarepta Therapeutics | Reata Pharmaceuticals vs. Krystal Biotech | Reata Pharmaceuticals vs. PTC Therapeutics | Reata Pharmaceuticals vs. Madrigal Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |